OPTIONS, TRADING
Lillian Currens
Deputy Editor,
Schaeffer's Investment Research, Inc.
Follow
About Lillian
Lillian Currens is the deputy editor at Schaeffer's Investment Research. She has been with Schaeffer's since 2018 and has over six years of experience writing and editing digital content. Ms. Currens also helps manage Schaeffer's social media, creating content for Instagram. In addition to her work at Schaeffer's, she has also written content for Forbes, City Beat, and other publications. Ms. Currens holds a bachelor's degree in art history and is currently pursuing her master's degrees in arts administration and business administration from the University of Cincinnati.
Lillian's Articles
Netflix (NFLX) stock recently got a boost following bull notes from at least two brokerages, observes Lillian Currens, deputy editor with the leading options advisory service, Schaeffer Investment Research.
Lillian Currens
CONSUMER
Tickers: NFLX
Biotechnology concern Vertex Pharmaceuticals Incorporated (VRTX) has been a standout during the past year, joining some of its sector peers in notable annual returns, observes Lillian Currens, deputy editor at Schaeffer's Investment Research.
Lillian Currens
HEALTHCARE
Tickers: VRTX
Chipmaker Nvidia Corporation (NVDA) hasn't been immune to the drubbing tech stocks (as well as the broader market) have faced so far this year, observes Lillian Currens, deputy editor of Schaeffer's Investment Research.
Lillian Currens
TECHNOLOGY
Tickers: NVDA
It's been a rough couple of months for blue-chip home improvement retailer Home Depot (HD); but our historical studies suggest the stock may be the best blue chip for options bulls this month, asserts Lillian Currens, deputy editor at Schaeffer Investment Research.
Lillian Currens
CONSUMER
Tickers: HD